Layered Signaling Regulatory Networks Analysis of Gene Expression Involved in Malignant Tumorigenesis of Non-Resolving Ulcerative Colitis via Integration of Cross-Study Microarray Profiles

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Fan, Shengjun ^a   Pan, Zhenyu ^b   Geng, Qiang ^c   Li, Xin ^a   Wang, Yefan ^a   An, Yu ^a   Xu, Yan ^d   Tie, Lu ^a   Pan, Yan ^a   Li, Xuejun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Xi'an Children Hospital   (China)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d QILU CHILDREN S HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN;

ARTICLE; BAYES THEOREM; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; COLORECTAL CANCER; CYTOPLASM; GENE EXPRESSION; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

CARCINOGENESIS; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84879364414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067142     Document Type: Article

References (118)

1. Boyle P, Langman JS, (2000) ABC of colorectal cancer: Epidemiology. BMJ 321: 805-808.
2. Boyle P, (1995) Progress in preventing death from colorectal cancer. Br J Cancer 72: 528-530.
3. Hendon SE, DiPalma JA, (2005) U.S. practices for colon cancer screening. Keio J Med 54: 179-183.
4. Devroede GJ, Taylor WF, Sauer WG, Jackman RJ, Stickler GB, (1971) Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 285: 17-21.
5. Yancik R, (2005) Population aging and cancer: a cross-national concern. Cancer J 11: 437-441.
6. Giovannucci E, Colditz GA, Stampfer MJ, Willett WC, (1996) Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7: 253-263.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
8. Rossi S, Kopetz S, Davuluri R, Hamilton SR, Calin GA, (2010) MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 42: 1291-1297.
9. Kanthan R, Senger JL, Kanthan SC, (2012) Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int 2012: 597497.
10. Nunnari G, Berretta M, Pinzone MR, Di Rosa M, Berretta S, et al. (2012) Hepatocellular carcinoma in HIV positive patients. Eur Rev Med Pharmacol Sci 16: 1257-1270.
11. Smolle E, Zohrer E, Bettermann K, Haybaeck J, (2012) Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings? Hepat Mon 12: e7879.
12. Hartnett L, Egan LJ, (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 33: 723-731.
13. Fuseya C, Horiuchi A, Hayashi A, Suzuki A, Miyamoto T, et al. (2012) Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis. Hum Pathol 43: 1964-1972.
14. Itzkowitz SH, Greenwald B, Meltzer SJ, (1995) Colon carcinogenesis in inflammatory bowel disease. Inflamm Bowel Dis 1: 142-158.
15. Lakatos PL, Lakatos L, (2012) Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis. Clin Gastroenterol Hepatol 10: 1179-1180.
16. Rubin DC, Shaker A, Levin MS, (2012) Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 3: 107.
17. Okayasu I, (2012) Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence. Pathol Int 62: 368-380.
18. Jiang W, Shadrach B, Carver P, Goldblum JR, Shen B, et al. (2012) Histomorphologic and molecular features of pouch and peripouch adenocarcinoma: a comparison with ulcerative colitis-associated adenocarcinoma. Am J Surg Pathol 36: 1385-1394.
19. de MatosSR, Tripathi S, Emmert-Streib F, (2012) Organizational structure and the periphery of the gene regulatory network in B-cell lymphoma. BMC Syst Biol 6: 38.
20. Gu Z, Zhang C, Wang J, (2012) Gene regulation is governed by a core network in hepatocellular carcinoma. BMC Syst Biol 6: 32.
21. Latchman DS, (1997) Transcription factors: an overview. Int J Biochem Cell Biol 29: 1305-1312.
22. Lee TI, Young RA, (2000) Transcription of eukaryotic protein-coding genes. Annu Rev Genet 34: 77-137.
23. Nikolov DB, Burley SK, (1997) RNA polymerase II transcription initiation: a structural view. Proc Natl Acad Sci U S A 94: 15-22.
24. Chen K, Rajewsky N, (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8: 93-103.
25. Kauffman S, (1974) The large scale structure and dynamics of gene control circuits: an ensemble approach. J Theor Biol 44: 167-190.
26. Kauffman SA, (1969) Metabolic stability and epigenesis in randomly constructed genetic nets. J Theor Biol 22: 437-467.
27. Rice JJ, Tu Y, Stolovitzky G, (2005) Reconstructing biological networks using conditional correlation analysis. Bioinformatics 21: 765-773.
28. Friedman N, (2004) Inferring cellular networks using probabilistic graphical models. Science 303: 799-805.
29. Chen T, He HL, Church GM (1999) Modeling gene expression with differential equations. Pac Symp Biocomput: 29-40.
30. Dehmer M, Emmert-Streib F (2009) Analysis of Complex Networks. Wiley-Blackwell.
31. Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, et al. (2006) ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7Suppl 1: S7.
32. Shalgi R, Lieber D, Oren M, Pilpel Y, (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3: e131.
33. Wu LF, Hughes TR, Davierwala AP, Robinson MD, Stoughton R, et al. (2002) Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters. Nat Genet 31: 255-265.
34. Walker MG, Volkmuth W, Sprinzak E, Hodgson D, Klingler T, (1999) Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. Genome Res 9: 1198-1203.
35. Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q, (2008) GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 9Suppl 1: S4.
36. Macarron R, Banks MN, Bojanic D, Burns DJ, Cirovic DA, et al. (2011) Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 10: 188-195.
37. Mullard A, (2012) Oncology trials gear up for high-throughput sequencing. Nat Rev Drug Discov 11: 339-340.
38. Zhang X, Zhao XM, He K, Lu L, Cao Y, et al. (2012) Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information. Bioinformatics 28: 98-104.
39. Zhu W, Yang L, Du Z, (2009) Layered functional network analysis of gene expression in human heart failure. PLoS One 4: e6288.
40. Kelly DJ, Ghosh S, (2005) RNA profiling for biomarker discovery: practical considerations for limiting sample sizes. Dis Markers 21: 43-48.
41. Xu L, Tan AC, Winslow RL, Geman D, (2008) Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics 9: 125.
42. Li J, Lenferink AE, Deng Y, Collins C, Cui Q, et al. (2010) Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun 1: 34.
43. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101: 9309-9314.
44. Woychik RP, Klebig ML, Justice MJ, Magnuson TR, Avner ED, (1998) Functional genomics in the post-genome era. Mutat Res 400: 3-14.
45. Xing B, van der Laan MJ, (2005) A causal inference approach for constructing transcriptional regulatory networks. Bioinformatics 21: 4007-4013.
46. Pedroso I, (2010) Gaining a pathway insight into genetic association data. Methods Mol Biol 628: 373-382.
47. Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R, (2006) A global analysis of cross-talk in a mammalian cellular signalling network. Nat Cell Biol 8: 571-580.
48. Cui Q, Ma Y, Jaramillo M, Bari H, Awan A, et al. (2007) A map of human cancer signaling. Mol Syst Biol 3: 152.
49. Fan S, Geng Q, Pan Z, Li X, Tie L, et al. (2012) Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol 6: 152.
50. van Lunteren E, Moyer M, (2009) Gene expression profiling in the type 1 diabetes rat diaphragm. PLoS One 4: e7832.
51. Andrew AS, Hu T, Gu J, Gui J, Ye Y, et al. (2012) HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One 7: e51301.
52. Mahurkar S, Moldovan M, Suppiah V, O'Doherty C, (2013) Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment. PLoS One 8: e57655.
53. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007) Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2: 2366-2382.
54. Martin A, Ochagavia ME, Rabasa LC, Miranda J, Fernandez-de-Cossio J, et al. (2010) BisoGenet: a new tool for gene network building, visualization and analysis. BMC Bioinformatics 11: 91.
55. Barsky A, Gardy JL, Hancock RE, Munzner T, (2007) Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 23: 1040-1042.
56. Gyorffy B, Molnar B, Lage H, Szallasi Z, Eklund AC, (2009) Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One 4: e5645.
57. Pekow J, Dougherty U, Huang Y, Gometz E, Nathanson J, et al. (2013) Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. Inflamm Bowel Dis 19: 461-470.
58. Xia X, McClelland M, Wang Y, (2005) WebArray: an online platform for microarray data analysis. BMC Bioinformatics 6: 306.
59. Chen R, Li L, Butte AJ, (2007) AILUN: reannotating gene expression data automatically. Nat Methods 4: 879.
60. Glaab E, Garibaldi JM, Krasnogor N, (2009) ArrayMining: a modular web-application for microarray analysis combining ensemble and consensus methods with cross-study normalization. BMC Bioinformatics 10: 358.
61. Tusher VG, Tibshirani R, Chu G, (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
62. Awan A, Bari H, Yan F, Moksong S, Yang S, et al. (2007) Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network. IET Syst Biol 1: 292-297.
63. Ma'Ayan A, Jenkins SL, Neves S, Hasseldine A, Grace E, et al. (2005) Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science 309: 1078-1083.
64. Bader GD, Hogue CW, (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4: 2.
65. Huang DW, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
66. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
67. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-W311.
68. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
69. Zhu H, Qian J, (2012) Applications of functional protein microarrays in basic and clinical research. Adv Genet 79: 123-155.
70. Tiwari M, (2012) Microarrays and cancer diagnosis. J Cancer Res Ther 8: 3-10.
71. de la Fuente A, (2010) From 'differential expression' to 'differential networking'- identification of dysfunctional regulatory networks in diseases. Trends Genet 26: 326-333.
72. Zakharkin SO, Kim K, Mehta T, Chen L, Barnes S, et al. (2005) Sources of variation in Affymetrix microarray experiments. BMC Bioinformatics 6: 214.
73. Procaccino F, Reinshagen M, Hoffmann P, Zeeh JM, Lakshmanan J, et al. (1994) Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 107: 12-17.
74. King AC, Cuatrecasas P, (1981) Peptide hormone-induced receptor mobility, aggregation, and internalization. N Engl J Med 305: 77-88.
75. Ishikawa S, Cepinskas G, Specian RD, Itoh M, Kvietys PR, (1994) Epidermal growth factor attenuates jejunal mucosal injury induced by oleic acid: role of mucus. Am J Physiol 267: G1067-G1077.
76. Luck MS, Bass P, (1993) Effect of epidermal growth factor on experimental colitis in the rat. J Pharmacol Exp Ther 264: 984-990.
77. Lafky JM, Wilken JA, Baron AT, Maihle NJ, (2008) Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 1785: 232-265.
78. Henson ES, Gibson SB, (2006) Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18: 2089-2097.
79. Berg M, Soreide K, (2012) EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy. Discov Med 14: 207-214.
80. Merla A, Goel S, (2012) Novel drugs targeting the epidermal growth factor receptor and its downstream pathways in the treatment of colorectal cancer: a systematic review. Chemother Res Pract 2012: 387172.
81. Bouscary D, Pene F, Claessens YE, Muller O, Chretien S, et al. (2003) Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 101: 3436-3443.
82. Mahida YR, Wu K, Jewell DP, (1989) Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30: 835-838.
83. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, et al. (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94: 174-181.
84. Smith MA, Knight SM, Maddison PJ, Smith JG, (1992) Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages. Ann Rheum Dis 51: 753-757.
85. Faquin WC, Schneider TJ, Goldberg MA, (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79: 1987-1994.
86. Lee JH, Sung DK, Koo SH, Shin BK, Hong YS, et al. (2007) Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. J Korean Med Sci 22: 1042-1047.
87. Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ, (2012) Ulcerative colitis. Lancet 380: 1606-1619.
88. Parray FQ, Wani ML, Malik AA, Wani SN, Bijli AH, et al. (2012) Ulcerative colitis: a challenge to surgeons. Int J Prev Med 3: 749-763.
89. Phillips TM, Kim K, Vlashi E, McBride WH, Pajonk F, (2007) Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia 9: 1122-1129.
90. Erslev AJ, Caro J, Miller O, Silver R, (1980) Plasma erythropoietin in health and disease. Ann Clin Lab Sci 10: 250-257.
91. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, et al. (1996) Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 334: 619-623.
92. Leyland-Jones B, (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4: 459-460.
93. Henke M, Laszig R, Rube C, Schafer U, Haase KD, et al. (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362: 1255-1260.
94. Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, et al. (2003) Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol 56: 209-213.
95. Yasuda Y, Fujita Y, Matsuo T, Koinuma S, Hara S, et al. (2003) Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 24: 1021-1029.
96. Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, et al. (2005) Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 7: 537-543.
97. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, et al. (2005) Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24: 4442-4449.
98. Dagnon K, Pacary E, Commo F, Antoine M, Bernaudin M, et al. (2005) Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. Clin Cancer Res 11: 993-999.
99. Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, et al. (2006) Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells. Prostate 66: 135-145.
100. McBroom JW, Acs G, Rose GS, Krivak TC, Mohyeldin A, et al. (2005) Erythropoietin receptor function and expression in epithelial ovarian carcinoma. Gynecol Oncol 99: 571-577.
101. Braegger CP (1994) Immunopathogenesis of chronic inflammatory bowel disease. Acta Paediatr Suppl 83: 18-21.
102. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316.
103. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
104. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, et al. (1996) T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241-251.
105. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL, (1994) Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179: 589-600.
106. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, et al. (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61: 4766-4772.
107. von Boehmer H, (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6: 338-344.
108. Steitz J, Bruck J, Lenz J, Knop J, Tuting T, (2001) Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res 61: 8643-8646.
109. Shimizu J, Yamazaki S, Sakaguchi S, (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5211-5218.
110. Snapper CM, Mond JJ, (1996) A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 157: 2229-2233.
111. Kristiansen SV, Pascual V, Lipsky PE, (1994) Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. J Immunol 153: 2974-2982.
112. Levy JA, (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57: 183-289.
113. Silverman GJ, (1997) B-cell superantigens. Immunol Today 18: 379-386.
114. DiLillo DJ, Matsushita T, Tedder TF, (2010) B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183: 38-57.
115. Zhang L, Zhao Y, (2007) The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J Cell Physiol 211: 590-597.
116. Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, et al. (2011) Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4(+) T cells to T-regulatory cells. Cancer Res 71: 3505-3515.
117. Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD, (2011) The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother 60: 609-619.
118. Barbera-Guillem E, Nelson MB, Barr B, Nyhus JK, May KJ, et al. (2000) B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion. Cancer Immunol Immunother 48: 541-549.